News

Science Daily5d
Scientists just found a major flaw in a key COVID drug study
A promising path to fighting COVID and other coronaviruses may have been based on a serious mistake. Scientists had zeroed in ...
Gene therapy restores hearing in toddlers and teenagers born with congenital deafness – new research
This is the first time such results have been achieved in both children and adult patients born with a specific type of ...
Team finds flawed data in recent study relevant to coronavirus antiviral development
The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid ...
TMCnet2d
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
Preclinical data support a novel combination of MB-101 (IL13Ra2-targeted CAR-T cell therapy) and MB-108 (HSV-1 oncolytic virus) to optimize clinical results FDA previously granted Orphan Drug ...
The Manila Times3h
Candel Therapeutics Expands Russell Index Presence with Addition to Multiple Value-Oriented Indexes in 2025 Reconstitution
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease ...
You could win a stay at Surf & Sand Laguna Beach in an oceanfront room
Text BEACH to 515151 for your chance to win two nights in an oceanfront room at Surf & Sand Laguna Beach, plus a $500 resort ...
Phys.org6d
Team finds flawed data in recent study relevant to coronavirus antiviral development - Phys.org
More information: Gabriel I. Small et al, The mechanism for GTP-mediated RNA capping by the SARS-CoV-2 NiRAN domain remains unresolved, Cell (2025). DOI: 10.1016/j.cell.2025.05.044 ...
BIOVAXYS ENGAGES ENCLAVE CAPITAL LLC TO ACT AS AN AGENT IN BROKERED PRIVATE PLACEMENT OFFERING
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces it has engaged Enclave Capital LLC ( ...
Taiwan News3h
Salarius Pharmaceuticals’ Seclidemstat Demonstrates Supporting Role in Inhibiting Validated Oncology Target LSD1 in Two Recently Published Studies
Salarius also announces continued progress in its planned merger with Decoy Therapeutics Inc. (Decoy). Under the definitive agreement announced on January 13, 2025, Decoy will merge with a wholly ...